Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2009

Open Access 01-12-2009 | Editorial

Colorectal Cancer Screening in the Elderly: The Need for Informed Decision Making

Authors: Richard M. Hoffman, MD, MPH, Louise C. Walter, MD

Published in: Journal of General Internal Medicine | Issue 12/2009

Login to get access

Excerpt

Colorectal cancer screening works! We have convincing evidence from randomized trials of fecal occult blood tests (FOBT) showing that colorectal cancer screening reduces disease-specific morbidity and mortality1. Case-control studies suggest that endoscopy is also effective24. Nonetheless, only about 60% of eligible adults are currently screened for colorectal cancer5. In contrast, nearly 75% of women are currently screened for breast cancer6, which has a similar level of evidence for efficacy as colorectal screening. More than 70% of men are currently screened for prostate cancer, which has uncertain efficacy7. The discordance between evidence and uptake of colorectal cancer screening has sparked considerable efforts to increase screening rates. However, the report by Kahi and colleagues suggests that these efforts may have the unintended consequence of promoting screening recommendations that fail to adequately consider the risks and benefits of screening in the context of a patient′s health status and life expectancy8. …
Literature
1.
go back to reference Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.CrossRefPubMed Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.CrossRefPubMed
2.
go back to reference Selby JV, Friedman GD, Quesenberry CP Jr., Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326(10):653–7.PubMedCrossRef Selby JV, Friedman GD, Quesenberry CP Jr., Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326(10):653–7.PubMedCrossRef
3.
go back to reference Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med. 1995;155(16):1741–8.CrossRefPubMed Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med. 1995;155(16):1741–8.CrossRefPubMed
4.
go back to reference Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150(1):1–8.PubMed Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150(1):1–8.PubMed
5.
go back to reference Use of colorectal cancer tests–United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep. 2008;57(10):253–8. Use of colorectal cancer tests–United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep. 2008;57(10):253–8.
6.
go back to reference Use of mammograms among women aged > or = 40 years–United States, 2000–2005. MMWR Morb Mortal Wkly Rep. 2007;56(3):49–51. Use of mammograms among women aged > or = 40 years–United States, 2000–2005. MMWR Morb Mortal Wkly Rep. 2007;56(3):49–51.
7.
go back to reference Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? Jama. 2003;289(11):1414–20.CrossRefPubMed Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? Jama. 2003;289(11):1414–20.CrossRefPubMed
8.
go back to reference Kahi CJ, van Ryn M, Juliar B, Stuart JS, Imperiale T. Provider recommendations for colorectal cancer screening in elderly veterans. J Gen Intern Med. 2009. doi:10.1007/s11606-009-1110-x Kahi CJ, van Ryn M, Juliar B, Stuart JS, Imperiale T. Provider recommendations for colorectal cancer screening in elderly veterans. J Gen Intern Med. 2009. doi:10.​1007/​s11606-009-1110-x
9.
go back to reference Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365–71.CrossRefPubMed Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365–71.CrossRefPubMed
10.
go back to reference Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603–7.CrossRefPubMed Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603–7.CrossRefPubMed
11.
go back to reference Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–37. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–37.
12.
go back to reference Walter LC, Lindquist K, Nugent S, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7):465–73.PubMed Walter LC, Lindquist K, Nugent S, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7):465–73.PubMed
13.
go back to reference Walter LC, Davidowitz NP, Heineken PA, Covinsky KE. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. Jama. 2004;291(20):2466–70.CrossRefPubMed Walter LC, Davidowitz NP, Heineken PA, Covinsky KE. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. Jama. 2004;291(20):2466–70.CrossRefPubMed
14.
go back to reference Fisher DA, Galanko J, Dudley TK, Shaheen NJ. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system. Clin Gastroenterol Hepatol. 2007;5(8):991–6.CrossRefPubMed Fisher DA, Galanko J, Dudley TK, Shaheen NJ. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system. Clin Gastroenterol Hepatol. 2007;5(8):991–6.CrossRefPubMed
Metadata
Title
Colorectal Cancer Screening in the Elderly: The Need for Informed Decision Making
Authors
Richard M. Hoffman, MD, MPH
Louise C. Walter, MD
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 12/2009
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-1121-7

Other articles of this Issue 12/2009

Journal of General Internal Medicine 12/2009 Go to the issue

Distinguished Reviewers

Distinguished Reviewers

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.